ELOXX PHARMACEUTICALS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
ELOXX PHARMACEUTICALS, INC. (ELOX) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 266 shares for the 6-month period ending 2026-06-30, per its S-1 filed 2026-09-11.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2026-09-11
- ELOXX PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2026-06-30 was 266.00 shares.
- ELOXX PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2026-03-31 was 0.00 shares.
- ELOXX PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2023-09-30 was 39.14K shares, a 2.70% decline year-over-year.
- ELOXX PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2023-06-30 was 4.64K shares, a 99.71% decline year-over-year.
- ELOXX PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2022 was 59.32K shares, a 95.70% decline from fiscal 2021.
- ELOXX PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2021 was 1.38M shares, a 40.51% decline from fiscal 2020.
- ELOXX PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2020 was 2.32M shares, a 824.33% increase from fiscal 2019.
- ELOXX PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2019 was 250.71K shares, a 24.33% decline from fiscal 2018.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 1 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | 266.00 shares derived: S-1 6 month − 10-Q 3 month · filed 2026-09-11 | 266.00 shares S-1 · filed 2026-09-11 | ||||
| 2026-03-31 | 0.00 shares 10-Q · filed 2026-05-05 | |||||
| 2025-12-31 | 337.00 shares S-1 · filed 2026-09-11 | 4.16K shares 10-K · filed 2026-03-17 | ||||
| 2023-09-30 | 39.14K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | 43.77K shares derived: sum of 2 quarters · filed 2023-11-13 | 59.41K shares 10-Q · filed 2023-11-13 | -1.57M shares derived: sum of 4 quarters · filed 2023-11-13 | ||
| 2023-06-30 | 4.64K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | 20.28K shares 10-Q · filed 2023-08-11 | -1.61M shares derived: sum of 3 quarters · filed 2023-08-11 | -1.57M shares derived: sum of 4 quarters · filed 2023-08-11 | ||
| 2023-03-31 | 15.64K shares 10-Q · filed 2023-05-12 | -1.61M shares derived: sum of 2 quarters · filed 2023-05-12 | -1.57M shares derived: sum of 3 quarters · filed 2023-05-12 | 31.80K shares derived: sum of 4 quarters · filed 2023-05-12 | ||
| 2022-12-31 | -1.63M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -1.59M shares derived: sum of 2 quarters · filed 2023-03-31 | 16.16K shares derived: sum of 3 quarters · filed 2023-03-31 | 59.32K shares 10-K · filed 2023-03-31 | ||
| 2022-09-30 | 40.22K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | 1.64M shares derived: sum of 2 quarters · filed 2022-11-10 | 1.69M shares 10-Q · filed 2022-11-10 | 1.79M shares derived: sum of 4 quarters · filed 2022-11-10 | ||
| 2022-06-30 | 1.60M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | 1.65M shares 10-Q · filed 2022-08-12 | 1.75M shares derived: sum of 3 quarters · filed 2022-08-12 | 2.22M shares derived: sum of 4 quarters · filed 2022-08-12 | ||
| 2022-03-31 | 43.16K shares 10-Q · filed 2022-05-06 | 143.51K shares derived: sum of 2 quarters · filed 2022-05-06 | 614.30K shares derived: sum of 3 quarters · filed 2022-05-06 | 1.34M shares derived: sum of 4 quarters · filed 2022-05-06 | ||
| 2021-12-31 | 100.35K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | 571.14K shares derived: sum of 2 quarters · filed 2022-03-30 | 1.29M shares derived: sum of 3 quarters · filed 2022-03-30 | 1.38M shares 10-K · filed 2022-03-30 | ||
| 2021-09-30 | 470.79K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | 1.19M shares derived: sum of 2 quarters · filed 2021-11-08 | 1.28M shares 10-Q · filed 2021-11-08 | 2.43M shares derived: sum of 4 quarters · filed 2021-11-08 | ||
| 2021-06-30 | 720.89K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | 807.39K shares 10-Q · filed 2021-08-16 | 1.96M shares derived: sum of 3 quarters · filed 2021-08-16 | 1.99M shares derived: sum of 4 quarters · filed 2021-08-16 | ||
| 2021-03-31 | 86.51K shares 10-Q · filed 2021-05-07 | 1.24M shares derived: sum of 2 quarters · filed 2021-05-07 | 1.27M shares derived: sum of 3 quarters · filed 2021-05-07 | 1.38M shares derived: sum of 4 quarters · filed 2021-05-07 | ||
| 2020-12-31 | 1.15M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | 1.18M shares derived: sum of 2 quarters · filed 2021-03-12 | 1.29M shares derived: sum of 3 quarters · filed 2021-03-12 | 2.32M shares 10-K · filed 2021-03-12 | ||
| 2020-09-30 | 30.31K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | 143.14K shares derived: sum of 2 quarters · filed 2020-11-06 | 1.17M shares 10-Q · filed 2020-11-06 | 1.26M shares derived: sum of 4 quarters · filed 2020-11-06 | ||
| 2020-06-30 | 112.83K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | 1.14M shares 10-Q · filed 2020-08-07 | 1.23M shares derived: sum of 3 quarters · filed 2020-08-07 | 1.30M shares derived: sum of 4 quarters · filed 2020-08-07 | ||
| 2020-03-31 | 1.02M shares 10-Q · filed 2020-05-08 | 1.12M shares derived: sum of 2 quarters · filed 2020-05-08 | 1.19M shares derived: sum of 3 quarters · filed 2020-05-08 | 1.15M shares derived: sum of 4 quarters · filed 2020-05-08 | ||
| 2019-12-31 | 97.16K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-06 | 164.91K shares derived: sum of 2 quarters · filed 2020-03-06 | 131.72K shares derived: sum of 3 quarters · filed 2020-03-06 | 250.71K shares 10-K · filed 2020-03-06 | ||
| 2019-09-30 | 67.75K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | 34.56K shares derived: sum of 2 quarters · filed 2019-11-06 | 153.55K shares 10-Q · filed 2019-11-06 | 165.74K shares derived: sum of 4 quarters · filed 2019-11-06 | ||
| 2019-06-30 | -33.19K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | 85.80K shares 10-Q · filed 2019-08-07 | 97.98K shares derived: sum of 3 quarters · filed 2019-08-07 | 268.67K shares derived: sum of 4 quarters · filed 2019-08-07 | ||
| 2019-03-31 | 119.00K shares 10-Q · filed 2019-05-09 | 131.18K shares derived: sum of 2 quarters · filed 2019-05-09 | 301.86K shares derived: sum of 3 quarters · filed 2019-05-09 | |||
| 2018-12-31 | 12.18K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | 182.87K shares derived: sum of 2 quarters · filed 2019-03-14 | 331.30K shares 10-K · filed 2019-03-14 | |||
| 2018-09-30 | 170.68K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | 319.12K shares 10-Q · filed 2018-11-08 | ||||
| 2018-06-30 | 148.44K shares 10-Q · filed 2018-08-10 | |||||
| 2014-11-18 | 85.50K shares 10-K · filed 2017-10-13 | |||||
| 2013-03-31 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2013-05-15 | 1.15M shares 10-Q · filed 2013-05-15 | ||||
| 2012-12-31 | 1.15M shares 10-Q · filed 2013-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Tevogen Inc. (TVGN) | United States | $0.049B |